<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01952184</url>
  </required_header>
  <id_info>
    <org_study_id>2013/777</org_study_id>
    <nct_id>NCT01952184</nct_id>
  </id_info>
  <brief_title>Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.</brief_title>
  <official_title>Oocyte Survival After Vitrification in an Open or Closed Commercial Device: Study on Sibling Donor Oocytes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The survival rate (and embryo quality) of donor oocytes with two commercially available
      devices.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Donor sibling oocytes will be vitrified with two commercially available devices. The first
      device is closed vitrification with closed storage and the second device is open
      vitrification with closed storage. Oocyte acceptors receive oocytes from both devices. With
      the increase in cooling rate generated by the open vitrification (second device), we expect
      to get an increase in survival rate of 10%. Besides this, embryo quality will be assessed
      with oocytes obtained from both devices.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival rate</measure>
    <time_frame>up to 6 days after every warming cycle</time_frame>
    <description>The purpose is to assess the survival rate of donor oocytes with the two vitrification devices.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Embryo development</measure>
    <time_frame>up to 6 days after every warming cycle</time_frame>
    <description>The purpose is to analyse the pre-implantation development of donor oocytes vitrified with two different devices.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Survival</condition>
  <condition>Embryo Quality</condition>
  <arm_group>
    <arm_group_label>closed vitrification with closed storage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Half of the oocytes of every donor will be vitrified with the Cryo Bio Systems High Security vitrification (CBSvit HS) device; the standard device in our lab.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>open vitrification with closed storage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Half of the oocytes of every donor will be vitrified with the Cryotop closed system (Cryotop SC).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CBSvit HS device</intervention_name>
    <description>closed vitrification with closed storage</description>
    <arm_group_label>closed vitrification with closed storage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryotop SC device</intervention_name>
    <description>open vitrification with closed storage</description>
    <arm_group_label>open vitrification with closed storage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Donor: ≤36 years old on day of oocyte retrieval

          -  Donor: ≥ 6 mature oocytes

        Exclusion Criteria:

          -  Donor: &lt; 6 mature oocytes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neelke De Munck, MSc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centrum voor Reproductieve Geneeskunde, UZBrussel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Jette</city>
        <state>Brussels</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2013</study_first_submitted>
  <study_first_submitted_qc>September 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2013</study_first_posted>
  <last_update_submitted>December 2, 2015</last_update_submitted>
  <last_update_submitted_qc>December 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Neelke De Munck</investigator_full_name>
    <investigator_title>MSc.</investigator_title>
  </responsible_party>
  <keyword>vitrification</keyword>
  <keyword>oocyte</keyword>
  <keyword>donor</keyword>
  <keyword>open</keyword>
  <keyword>closed</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

